SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...
Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary Biomedical. “Infusion sets ...
Study Overview: Tandem Diabetes Care has launched a feasibility study called “Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes.” The study ...
Tandem Diabetes Care (Nasdaq:TNDM) today shared first-quarter financial results that came in ahead of the consensus forecast ...
Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its ...